Navigation Links
ATS Medical Announces Third Quarter 2009 Results
Date:11/2/2009

=======
    ATS Medical, Inc.
    Selected Revenue Information
    (in thousands)
    --------------

                                 Quarter Ended      Nine Months Ended
                                 -------------      -----------------
                             October    September October     September
                                3,          27,       3,          27,
                               2009        2008      2009        2008
                               ----        ----      ----        ----

    Heart valve therapy     $14,163      $11,755   $42,144     $34,529
    Surgical arrhythmia       4,491        4,011    14,117      12,245
    Surgical tools &
     accessories                173          278       750       1,015
                                ---          ---       ---       -----

      Total revenue         $18,827      $16,044   $57,011     $47,789
                            =======      =======   =======     =======



    ATS Medical, Inc.
    Reconciliation of GAAP
     Net Loss to Non-GAAP
     EBITDA
    (Unaudited, in thousands)
    -------------------------

                                      Quarter Ended    Nine Months Ended
                                      -------------    -----------------
                                    October  September October  September
                                       3,       27,       3,       27,
                                      2009     2008     2009      2008
                                      ----     ----     ----      ----



    Net loss, as reported            $(975)  $(3,746) $(2,832) $(10,826)
    Adjustments to net loss:
        Interest expense               648       729    2,081     2,151
        Income tax  expense            132        55      314       284
        Depreciation                   476       494    1,416     1,659
        Amortization of intangibles    812       891    2,412     2,672
                   
'/>"/>
SOURCE ATS Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014 Research and Markets has ... Production Markets" report to their offering. ... vaccines - including products to treat cancer, diabetes, HIV/AIDS ... during the final stages of clinical drug testing for ... risk production capital to upscale while anticipating FDA or ...
(Date:9/23/2014)... , Sept 23, 2014  Vesselon, Inc. today announced ... of Directors, effective September 15, 2014. Dr. Raths, appointment ... its placement agent to market a private preferred Series ... early stroke treatment. "Jurgen,s deep experience across ... a great asset to Vesselon as we develop our ...
(Date:9/23/2014)... Cerevast Therapeutics Inc., a privately held ... the first interim analysis of its ongoing Phase ... Clotbust ER TM ultrasonic headframe for ... Data Safety Monitoring Board (DSMB) has recommended the ... the pre-specified futility threshold and four independent safety ...
Breaking Medicine Technology:Biopharmaceutical and Vaccine Production Markets 2Biopharmaceutical and Vaccine Production Markets 3Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 2Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 3Cerevast Therapeutics Announces Outcome of First Interim Analysis of Phase 3 CLOTBUSTER Trial for the Treatment of Acute Ischemic Stroke 2Cerevast Therapeutics Announces Outcome of First Interim Analysis of Phase 3 CLOTBUSTER Trial for the Treatment of Acute Ischemic Stroke 3
(Date:9/23/2014)... (PRWEB) September 23, 2014 Oaksterdam University ... Today . In its first post, the University addresses ... and changing cannabis industry. , The cannabis industry is ... alone is expecting an 18-month boost of more than ... adult use pot sales. And, the new legal recreational ...
(Date:9/23/2014)... NIH TO CONVENE PATHWAYS TO PREVENTION WORKSHOP: ROLE OF ... WHAT: , The National Institutes of Health is ... available scientific evidence on the long-term effectiveness and potential ... be among the nation,s top experts in the field ... as well as key NIH scientists who focus on ...
(Date:9/23/2014)... 2014 As a consumer in today’s ... purchase. It’s difficult to trust testimonials that are supplied ... to manipulate their customers into saying anything. , Consumer ... tend to lack in depth coverage on a particular ... founded to fix this issue and focus on exposing ...
(Date:9/23/2014)... Sept. 23, 2014 (HealthDay News) -- Both drinking and ... factors for alcohol abuse by high school students, a ... survey of high school students who drink, could help ... who already drink, to stop them from becoming binge ... between age of first alcohol use and progression to ...
(Date:9/23/2014)... 23, 2014 What: Rutgers Presbyterian ... West Side that embodies the inclusion and diversity ... Scripture and the Ecological Crisis, a public lecture ... Professor Emerita of Old Testament at Louisville Presbyterian ... wisdom that lends insight into current ecological problems, ...
Breaking Medicine News(10 mins):Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 2Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 3Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 2Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 3Health News:Consumer Health Reports Debuts Revolutionary Review Website 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 3Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2
... Annual and Special Meeting web cast live, LAVAL, ... Special,meeting of Neurochem Inc. (NASDAQ: NRMX ; TSX: ... new name, BELLUS Health Inc., which,it expects to start ... stock,ticker symbols (NASDAQ: BLUS ; TSX: BLU). Neurochem ...
... 15 Heritage Pharma Ltd.,(U.K.) and its wholly ... the Company has consummated the,private placement of Series ... capital investors McClendon Venture Company, LLC and,TLW Venture ... prior to fees,and expenses. The proceeds will be ...
... a high frequency of sleep-related breathing disorders (SRBD) in ... an overnight sleep test, especially in patients with underlying ... April 15 issue of the Journal of Clinical Sleep ... MD, of Johns Hopkins University and Bayview Medical Center ...
... Allergies and asthma affect,six times more Americans than ... America. As the fifth leading chronic disease, allergies,along ... Americans., (Photo: http://www.newscom.com/cgi-bin/prnh/20080415/NYTUFNS1 ), ... to prevent or treat,allergies and asthma," said Peggy ...
... therapy shows promise against pancreatic tumors, scientists say , , ... drug duo might help prevent colorectal cancer, and the ... of liver cancer. , So conclude two studies presented ... meeting in San Diego. , In the first report, ...
... Position Company to Meet Strategic ... Growth Objectives, ... global full-service clinical research organization, today,announced the promotion of Simon S. ... as President and Chief Operating,Officer, will continue as Chief Operating Officer. ...
Cached Medicine News:Health News:At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM) 2Health News:At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM) 3Health News:At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM) 4Health News:At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM) 5Health News:At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM) 6Health News:Heritage Announces $10 Million Financing 2Health News:JCSM: A high frequency of sleep-related breathing disorders in hospitalized patients 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Allergies and Asthma Relief 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Allergies and Asthma Relief 3Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Allergies and Asthma Relief 4Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Allergies and Asthma Relief 5Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Allergies and Asthma Relief 6Health News:New Treatments Help Fight Liver, Colon Cancer 2Health News:New Treatments Help Fight Liver, Colon Cancer 3Health News:New Treatments Help Fight Liver, Colon Cancer 4Health News:Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer 2Health News:Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer 3
Indications For Usage: , ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hou...
... T helps provide protection to the exposed airway ... extremely lightweight making it ideal for active young ... rate of heat and moisture recovery, it ensures ... HMEs and filters have ISO standard tapered ends ...
... The Portex® Thermovent® T helps provide protection to ... is small and extremely lightweight making it ideal ... With a high rate of heat and moisture ... retention., ,All HMEs and filters have ISO ...
For use with: , pulmonary function testing , nebulizer compressors , humidifiers , concentrators , proximal pressure lines ...
Medicine Products: